• Biophytis shareholders will vote on capital-raising authorizations with nominal ceilings of EUR 38 million for share capital increases and EUR 40 million for debt securities.
• Private placements would be capped at 30% of capital annually; proposed offerings without preferential subscription rights would allow discounts up to 25%.
• Proposals include a reverse split exchanging up to 100 existing shares for one new share, alongside reductions in nominal value.
• A proposed buyback covers up to 10% of capital at EUR 0.10 per share, with a separate authorization to cancel repurchased shares.
• Jean Mariani is nominated for a three-year board term, ending at the 2029 shareholder meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biophytis SA published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.